U.S.
Rhythm Pharmaceuticals up 28% on an AstraZeneca bid report. Its 8-K never mentions a deal
Kyndryl and Duolingo rose on earnings; Rhythm Pharmaceuticals rose on a reported $10 billion AstraZeneca bid that no filing confirms.
Every time Rhythm Pharmaceuticals, Inc. (RYTM) moved sharply, checked against filings and numbers. 1 article(s), newest first.
Kyndryl and Duolingo rose on earnings; Rhythm Pharmaceuticals rose on a reported $10 billion AstraZeneca bid that no filing confirms.